Recognition of melanoma cell antigens with antibodies present in sera from patients with vitiligo

被引:12
作者
Rocha, IM
Oliveira, LJN
de Castro, LCM
Pereira, LID
Chaul, A
Guerra, JG
Silvestre, MC
Batista, KM
Pereira, FA
Gomide, MAC
Guillo, LA
机构
[1] Univ Goias, Dept Physiol Sci & Trop Med, Goiania, Go, Brazil
[2] Univ Goias, Dept Publ Hlth, Goiania, Go, Brazil
[3] Univ Goias, Dept Dermatol, Goiania, Go, Brazil
关键词
D O I
10.1046/j.1365-4362.2000.00089.x
中图分类号
R75 [皮肤病学与性病学];
学科分类号
100206 ;
摘要
Background Patients with vitiligo show specific losses of integumentary melanocytes, probably due to autoimmunity against melanocytes. We attempted to determine the presence of antibodies against pigment cell antigens in the sera of vitiligo patients. Methods Detergent-solubilized human melanoma cells were submitted to electrophoretic separation and immunoblotted against serum samples obtained from 19 patients with vitiligo and from 20 age- and sex-matched healthy individuals. Results Eighty-nine per cent of patients with vitiligo had antibodies to one or more pigment cell antigens. Similar antibodies were detected in 20% of healthy individuals. Antigens of 165, 90, and 68 kDa were recognized by the antibodies present in sera from 11%, 26%, and 37% of vitiligo patients, respectively, and in none of the normal sera. All patients with familial vitiligo also had antibodies to these three proteins. Conclusions Proteins of 165, 90, and 68 kDa are specifically recognized by antibodies present in the sera of vitiligo patients and in all patients with genetic vitiligo. Whether or not these proteins might be implicated in the destruction of melanocytes by the immune system in vitiligo remains to be evaluated.
引用
收藏
页码:840 / 843
页数:4
相关论文
共 20 条
[1]   MELANOCYTE LINEAGE-SPECIFIC ANTIGEN GP100 IS RECOGNIZED BY MELANOMA-DERIVED TUMOR-INFILTRATING LYMPHOCYTES [J].
BAKKER, ABH ;
SCHREURS, MWJ ;
DEBOER, AJ ;
KAWAKAMI, Y ;
ROSENBERG, SA ;
ADEMA, GJ ;
FIGDOR, CG .
JOURNAL OF EXPERIMENTAL MEDICINE, 1994, 179 (03) :1005-1009
[2]  
BARARAV E, 1995, MELANOMA RES, V5, P337
[3]   IDENTIFICATION OF PIGMENT CELL ANTIGENS DEFINED BY VITILIGO ANTIBODIES [J].
CUI, J ;
HARNING, R ;
HENN, M ;
BYSTRYN, JC .
JOURNAL OF INVESTIGATIVE DERMATOLOGY, 1992, 98 (02) :162-165
[4]   CHARACTERIZATION OF VITILIGO ANTIGENS [J].
CUI, JA ;
ARITA, Y ;
BYSTRYN, JC .
PIGMENT CELL RESEARCH, 1995, 8 (01) :53-59
[5]  
Fishman P, 1997, CANCER, V79, P1461, DOI 10.1002/(SICI)1097-0142(19970415)79:8<1461::AID-CNCR3>3.0.CO
[6]  
2-E
[7]  
HERLYN M, 1987, CANCER RES, V47, P3057
[8]   SURFACE-ANTIGENS OF MELANOCYTES AND MELANOMAS - MARKERS OF MELANOCYTE DIFFERENTIATION AND MELANOMA SUBSETS [J].
HOUGHTON, AN ;
EISINGER, M ;
ALBINO, AP ;
CAIRNCROSS, JG ;
OLD, LJ .
JOURNAL OF EXPERIMENTAL MEDICINE, 1982, 156 (06) :1755-1766
[9]   Detection of tyrosinase autoantibodies in patients with vitiligo using S-35-labeled recombinant human tyrosinase in a radioimmunoassay [J].
Kemp, EH ;
Gawkrodger, DJ ;
MacNeil, S ;
Watson, PF ;
Weetman, AP .
JOURNAL OF INVESTIGATIVE DERMATOLOGY, 1997, 109 (01) :69-73
[10]  
Kemp EH, 1998, CLIN EXP IMMUNOL, V114, P333